Squarepoint’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$798K Sell
37,001
-10,448
-22% -$194K ﹤0.01% 3074
2026
Q1
$806K Buy
47,449
+30,885
+186% +$525K ﹤0.01% 2958
2025
Q4
$311K Buy
+16,564
New +$250K ﹤0.01% 3580
2024
Q4
Sell
-46,224
Closed -$1.06M 5360
2024
Q3
$1.06M Buy
46,224
+9,415
+26% +$213K ﹤0.01% 2566
2024
Q2
$845K Buy
+36,809
New +$1.13M ﹤0.01% 2684
2020
Q1
Sell
-6,980
Closed -$460K 2313
2019
Q4
$460K Sell
6,980
-8,005
-53% -$489K ﹤0.01% 1818
2019
Q3
$865K Buy
14,985
+11,485
+328% +$712K 0.01% 1334
2019
Q2
$202K Buy
+3,500
New +$162K ﹤0.01% 2101

Other funds holding NRC

Squarepoint's NRC Position: Q2 2026 in Review

Squarepoint reduced its NRC Health Common Stock (NRC) stake by 22% in Q2 2026, selling an estimated $194K and leaving 37,001 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

Squarepoint first reported a position in NRC in Q2 2019 and has held it in 8 quarters since. The position peaked at $1.06M in Q3 2024. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Squarepoint held 37,001 shares of NRC Health Common Stock worth $798K as of Q2 2026.
  • Squarepoint sold 10,448 NRC Health Common Stock shares in Q2 2026, an estimated $194K.
  • NRC Health Common Stock made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3074 holding.
  • Squarepoint first reported a position in NRC Health Common Stock in Q2 2019 and has held it in 8 quarters since.
  • Squarepoint's NRC Health Common Stock position peaked at $1.06M in Q3 2024.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.